6.50 % to Target, Jefferies Maintains ‘”Buy”’ Rating on Wright Medical Group (NASDAQ:WMGI) Shares Today

August 10, 2018 - By Mary Kidd

Wright Medical Group N.V. (NASDAQ:WMGI) Logo

Wright Medical Group (NASDAQ:WMGI) Rating Reaffirmed

Jefferies now has a $30 PT on shares of Wright Medical Group (NASDAQ:WMGI). The PT gives a potential upside of 6.50 % from the current stock price of Wright Medical Group (NASDAQ:WMGI). This rating was released in a report on Thursday, 9 August.

Wright Medical Group N.V. (NASDAQ:WMGI) Ratings Coverage

Among 9 analysts covering Wright Medical Group (NASDAQ:WMGI), 8 have Buy rating, 0 Sell and 1 Hold. Therefore 89% are positive. Wright Medical Group has $35 highest and $25 lowest target. $30.13’s average target is 6.96% above currents $28.17 stock price. Wright Medical Group had 17 analyst reports since February 12, 2018 according to SRatingsIntel. On Monday, April 30 the stock rating was maintained by Cantor Fitzgerald with “Buy”. The stock has “Outperform” rating by BMO Capital Markets on Wednesday, February 28. Cantor Fitzgerald maintained Wright Medical Group N.V. (NASDAQ:WMGI) on Monday, March 12 with “Buy” rating. Guggenheim upgraded Wright Medical Group N.V. (NASDAQ:WMGI) on Wednesday, June 13 to “Buy” rating. The company was maintained on Monday, February 12 by Cantor Fitzgerald. The firm has “Buy” rating by Cantor Fitzgerald given on Thursday, June 21. Barclays Capital maintained Wright Medical Group N.V. (NASDAQ:WMGI) on Wednesday, February 28 with “Overweight” rating. On Thursday, August 9 the stock rating was maintained by Robert W. Baird with “Outperform”. The rating was maintained by Cantor Fitzgerald with “Buy” on Monday, May 21. The firm has “Buy” rating by Robert W. Baird given on Wednesday, February 28.

The stock increased 0.11% or $0.03 during the last trading session, reaching $28.17. About 27,203 shares traded. Wright Medical Group N.V. (NASDAQ:WMGI) has declined 9.52% since August 10, 2017 and is downtrending. It has underperformed by 22.09% the S&P500.

Wright Medical Group N.V., a medical device company, designs, makes, markets, and sells extremities and biologics products.in the United States, Europe, the Middle East, Africa, and internationally. The company has market cap of $2.99 billion. The firm offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It currently has negative earnings. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries.

More notable recent Wright Medical Group N.V. (NASDAQ:WMGI) news were published by: Benzinga.com which released: “68 Stocks Moving In Thursday’s Mid-Day Session” on August 09, 2018, also Nasdaq.com with their article: “Detailed Research: Economic Perspectives on Veritiv, Wright Medical Group NV, Ollie’s Bargain Outlet, Compass …” published on July 25, 2018, Benzinga.com published: “Benzinga’s Top Upgrades, Downgrades For August 9, 2018” on August 09, 2018. More interesting news about Wright Medical Group N.V. (NASDAQ:WMGI) were released by: Streetinsider.com and their article: “Wright Medical (WMGI) PT Raised to $32 at RBC Capital” published on August 09, 2018 as well as Benzinga.com‘s news article titled: “40 Stocks Moving In Thursday’s Pre-Market Session” with publication date: August 09, 2018.

Wright Medical Group N.V. (NASDAQ:WMGI) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.